{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T09:39:23Z","timestamp":1771493963682,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.lfs.2013.01.007","type":"journal-article","created":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T01:31:40Z","timestamp":1358299900000},"page":"311-316","source":"Crossref","is-referenced-by-count":18,"title":["Increased melatonin may play dual roles in the striata of a 6-hydroxydopamine model of Parkinson's disease"],"prefix":"10.1016","volume":"92","author":[{"given":"Ling","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2013.01.007_bb0010","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/0748730407308167","article-title":"Interactions between dopamine and melatonin organize circadian rhythmicity in the retina of the green iguana","volume":"22","author":"Bartell","year":"2007","journal-title":"J Biol Rhythms"},{"key":"10.1016\/j.lfs.2013.01.007_bb0015","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1600-079X.2009.00713.x","article-title":"Melatonin inhibits 6-hydroxydopamine production in the brain to protect against experimental parkinsonism in rodents","volume":"47","author":"Borah","year":"2009","journal-title":"J Pineal Res"},{"key":"10.1016\/j.lfs.2013.01.007_bb0020","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00002826-200303000-00005","article-title":"Study of circadian melatonin secretion patterns at different stages of Parkinson's disease","volume":"26","author":"Bordet","year":"2003","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.lfs.2013.01.007_bb0025","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1046\/j.1471-4159.2003.01904.x","article-title":"Microdialysis of dopamine interpreted with quantitative model incorporating probe implantation trauma","volume":"86","author":"Bungay","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.lfs.2013.01.007_bb0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejphar.2008.07.022","article-title":"Melatonin attenuates tyrosine hydroxylase loss and hypolocomotion in MPTP-lesioned rats","volume":"594","author":"Capitelli","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.lfs.2013.01.007_bb0035","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1087-0792(98)90020-X","article-title":"Basic aspects of melatonin action","volume":"2","author":"Cardinali","year":"1998","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.lfs.2013.01.007_bb0040","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1096\/fj.00-0129com","article-title":"Melatonin protects against 6-OHDA-nduced neurotoxicity in rats: a role for mitochondrial complex I activity","volume":"15","author":"Dabbeni-Sala","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.lfs.2013.01.007_bb1000","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/exnr.2002.7891","article-title":"Modeling Parkinson\u2019s disease in rats: an evaluation of 6-OHDA lesions of the nigrosrtiatal pathway","volume":"175","author":"Deumens","year":"2002","journal-title":"Exp Neurol"},{"key":"10.1016\/j.lfs.2013.01.007_bb0045","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.parkreldis.2008.07.008","article-title":"Does melatonin help save dopaminergic cells in MPTP-treated mice?","volume":"15","author":"Ma","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.lfs.2013.01.007_bb0050","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0006-8993(98)01262-1","article-title":"Ultrastructural confirmation of neuronal protection by melatonin against the neurotoxin 6-hydroxydopamine cell damage","volume":"818","author":"Mayo","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.lfs.2013.01.007_bb0055","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0166-4328(96)00083-6","article-title":"Neural control of the pineal gland","volume":"73","author":"Moore","year":"1996","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.lfs.2013.01.007_bb0060","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0006-8993(01)03106-7","article-title":"Chronic administration of pharmacological levels of melatonin does not ameliorate the MPTP-induced degeneration of the nigrostriatal pathway","volume":"921","author":"Morgan","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.lfs.2013.01.007_bb0065","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.2527\/2001.79112895x","article-title":"Nocturnal melatonin and prolactin plasma concentrations in sheep selected for fertility in autumn lambing","volume":"79","author":"Notter","year":"2001","journal-title":"J Anim Sci"},{"key":"10.1016\/j.lfs.2013.01.007_bb0070","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/mds.21542","article-title":"Bright light therapy in Parkinson's disease: a pilot study","volume":"22","author":"Paus","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.lfs.2013.01.007_bb0075","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"2006"},{"key":"10.1016\/j.lfs.2013.01.007_bb0080","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/1099-0801(200008)14:5<306::AID-BMC986>3.0.CO;2-7","article-title":"Quantitative determination of melatonin in human plasma and cerebrospinal fluid with high performance liquid chromatography and fluorescence detection","volume":"14","author":"Sastre Tora\u00f1o","year":"2000","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.lfs.2013.01.007_bb0085","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10552-005-9002-9","article-title":"Circulating melatonin levels: possible link between Parkinson's disease and cancer risk?","volume":"17","author":"Schernhammer","year":"2006","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.lfs.2013.01.007_bb0090","first-page":"419","article-title":"Neuroprotection of the nigrostriatal dopaminergic neurons by melatonin in hemiparkinsonium rat","volume":"124","author":"Singh","year":"2006","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.lfs.2013.01.007_bb0095","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s12035-011-8225-x","article-title":"Melatonin as a neuroprotective agent in the rodent models of Parkinson's disease: is it all set to irrefutable clinical translation?","volume":"45","author":"Singhal","year":"2012","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.lfs.2013.01.007_bb0100","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/jnr.22201","article-title":"Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model","volume":"88","author":"Tapias","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.lfs.2013.01.007_bb0105","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.brainres.2008.03.083","article-title":"Intraocular microinjections repair experimental Parkinson's disease","volume":"1217","author":"Willis","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.lfs.2013.01.007_bb0110","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1515\/REVNEURO.2008.19.4-5.245","article-title":"Parkinson's disease as a neuroendocrine disorder of circadian function: dopamine-melatonin imbalance and the visual system in the genesis and progression of the degenerative process","volume":"19","author":"Willis","year":"2008","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.lfs.2013.01.007_bb0115","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0031-9384(99)00023-2","article-title":"A therapeutic role for melatonin antagonism in experimental models of Parkinson's disease","volume":"66","author":"Willis","year":"1999","journal-title":"Physiol Behav"},{"key":"10.1016\/j.lfs.2013.01.007_bb0125","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.pbb.2004.08.011","article-title":"Recovery of experimental Parkinson's disease with the melatonin analogues ML-23 and S-20928 in a chronic, bilateral 6-OHDA model: a new mechanism involving antagonism of the melatonin receptor","volume":"79","author":"Willis","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.lfs.2013.01.007_bb0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bbr.2008.04.017","article-title":"Compromised circadian function in Parkinson's disease: enucleation augments disease severity in the unilateral model","volume":"193","author":"Willis","year":"2008","journal-title":"Behav Brain Res"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432051300012X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432051300012X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T09:56:18Z","timestamp":1539942978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432051300012X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":25,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S002432051300012X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2013.01.007","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}